Impact of Intra- and Postoperative Blood Transfusion on the Incidence, Timing, and Pattern of Disease Recurrence After Radical Cystectomy

Clinical Genitourinary Cancer

Volumn 15, Issue 4, 2017, Pages e681-e688

  Moschini, Marco ^a,b,c   Soria, Francesco ^b,d   Abufaraj, Mohammad ^b,e   Foerster, Beat ^b,e   D'Andrea, David ^b,e   Damiano, Rocco ^c   Klatte, Tobias ^b,e   Montorsi, Francesco ^a   Briganti, Alberto ^a   Colombo, Renzo ^a   Gallina, Andrea ^a   Shariat, Shahrokh F ^b,e,f,g  

^a VITA SALUTE SAN RAFFAELE UNIVERSITY   (Italy)

^b MEDICAL UNIVERSITY OF VIENNA   (Austria)

^c UNIVERSITY MAGNA GRAECIA OF CATANZARO   (Italy)

^d UNIVERSITY OF TURIN   (Italy)

^e KARL LANDSTEINER INSTITUTE OF UROLOGY AND ANDROLOGY   (Austria)

^f NEW YORK PRESBYTERIAN HOSPITAL   (United States)

^g UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

Bladder cancer; Intraoperative transfusion; Radical cystectomy; Recurrence; Transfusion

Indexed keywords

ADULT; AGED; ARTICLE; BLADDER CANCER; BLOOD TRANSFUSION; BONE CANCER; BRAIN CANCER; CANCER RECURRENCE; CONTROLLED STUDY; CYSTECTOMY; FEMALE; FOLLOW UP; HUMAN; INCIDENCE; INTRAOPERATIVE PERIOD; LIVER CANCER; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; PELVIS LYMPH NODE; PELVIS LYMPHADENECTOMY; PERITONEUM CANCER; POSTOPERATIVE PERIOD; SURVIVAL ANALYSIS; BLADDER TUMOR; BLOOD TRANSFUSION REACTION; EPIDEMIOLOGY; MIDDLE AGED; PERIOPERATIVE PERIOD; PROCEDURES; TREATMENT OUTCOME; TUMOR RECURRENCE;

AGED; BLOOD TRANSFUSION; CYSTECTOMY; FEMALE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PERIOPERATIVE CARE; TRANSFUSION REACTION; TREATMENT OUTCOME; URINARY BLADDER NEOPLASMS;

EID: 85011291946     PISSN: 15587673     EISSN: 19380682     Source Type: Journal    
DOI: 10.1016/j.clgc.2017.01.001     Document Type: Article

References (22)

1. Qiu, M., Yuan, Z., Luo, H., et al. Impact of pretreatment hematologic profile on survival of colorectal cancer patients. Tumour Biol 31 (2010), 255–260.
2. Yeoh, T.Y., Scavonetto, F., Weingarten, T.N., et al. Perioperative allogeneic nonleukoreduced blood transfusion and prostate cancer outcomes after radical prostatectomy. Transfusion 54 (2014), 2175–2181.
3. Churchhouse, A.M.D., Mathews, T.J., McBride, O.M.B., Dunning, J., Does blood transfusion increase the chance of recurrence in patients undergoing surgery for lung cancer?. Interact Cardiovasc Thorac Surg 14 (2012), 85–90.
4. Linder, B.J., Frank, I., Cheville, J.C., et al. The impact of perioperative blood transfusion on cancer recurrence and survival following radical cystectomy. Eur Urol 63 (2013), 839–845.
5. Moschini, M., Bianchi, M., Gandaglia, G., et al. The impact of perioperative blood transfusion on survival of bladder cancer patients submitted to radical cystectomy: role of anemia status. Eur Urol Focus, 2015, 10.1016/j.euf.2015.03.002.
6. Cata, J.P., Lasala, J., Pratt, G., Feng, L., Shah, J.B., Association between perioperative blood transfusions and clinical outcomes in patients undergoing bladder cancer surgery: a systematic review and meta-analysis study. J Blood Transfus 2016 (2016), 1–8.
7. Abel, E.J., Linder, B.J., Bauman, T.M., et al. Perioperative blood transfusion and radical cystectomy: does timing of transfusion affect bladder cancer mortality?. Eur Urol 66 (2014), 1139–1147.
8. Moschini, M., Dell' Oglio, P., Capogrosso, P., et al. Effect of allogeneic intraoperative blood transfusion on survival in patients treated with radical cystectomy for nonmetastatic bladder cancer: results from a single high-volume institution. Clin Genitourin Cancer 13 (2015), 562–567.
9. Vamvakas, E.C., Blajchman, M.A., Transfusion-related immunomodulation (TRIM): an update. Blood Rev 21 (2007), 327–348.
10. Colvin, L.A., Fallon, M.T., Buggy, D.J., Cancer biology, analgesics, and anaesthetics: is there a link?. Br J Anaesth 109 (2012), 140–143.
11. Pesta, M., Fichtl, J., Kulda, V., Topolcan, O., Treska, V., Monitoring of circulating tumor cells in patients undergoing surgery for hepatic metastases from colorectal cancer. Anticancer Res 33 (2013), 2239–2243.
12. Zaid, H.B., Yang, D.Y., Tollefson, M.K., et al. Efficacy and safety of intraoperative tranexamic acid infusion for reducing blood transfusion during open radical cystectomy. Urology 92 (2016), 57–62.
13. Nguyen, D.P., Al Hussein Al Awamlh, B., Wu, X., et al. Recurrence patterns after open and robot-assisted radical cystectomy for bladder cancer. Eur Urol 68 (2015), 399–405.
14. Shariat, S.F., Svatek, R.S., Tilki, D., et al. International validation of the prognostic value of lymphovascular invasion in patients treated with radical cystectomy. BJU Int 105 (2010), 1402–1412.
15. Novara, G., Svatek, R.S., Karakiewicz, P.I., et al. Soft tissue surgical margin status is a powerful predictor of outcomes after radical cystectomy: a multicenter study of more than 4,400 patients. J Urol 183 (2010), 2165–2170.
16. Moschini, M., Bianchi, M., Rossi, M.S., et al. Timing of blood transfusion and not ABO blood type is associated with survival in patients treated with radical cystectomy for nonmetastatic bladder cancer: results from a single high-volume institution. Urol Oncol 34 (2016), 256.e7–256.e13.
17. Moschini, M., Karnes, R.J., Sharma, V., et al. Patterns and prognostic significance of clinical recurrences after radical cystectomy for bladder cancer: a 20-year single center experience. Eur J Surg Oncol 42 (2016), 735–743.
18. Cornu, J.N., Neuzillet, Y., Hervé, J.M., Yonneau, L., Botto, H., Lebret, T., Patterns of local recurrence after radical cystectomy in a contemporary series of patients with muscle-invasive bladder cancer. World J Urol 30 (2012), 821–826.
19. Boorjian, S.A., Kim, S.P., Weight, C.J., Cheville, J.C., Thapa, P., Frank, I., Risk factors and outcomes of urethral recurrence following radical cystectomy. Eur Urol 60 (2011), 1266–1272.
20. Moschini, M., Gallina, A., Freschi, M., et al. Effect on postoperative survival of the status of distal ureteral margin: the necessity to achieve negative margins at the time of radical cystectomy. Urol Oncol, 34, 2016, 59 e15-22.
21. Vamvakas, E.C., Possible mechanisms of allogeneic blood transfusion-associated postoperative infection. Transfus Med Rev 16 (2002), 144–160.
22. Masse, M., Universal leukoreduction of cellular and plasma components: process control and performance of the leukoreduction process. Transfus Clin Biol 8 (2001), 297–302.